CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 120 filers reported holding CUREVAC N V in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $12,491,000 | – | 170,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |